In the BioHarmony Drug Report Database
Mavyret, Maviret (glecaprevir) is a small molecule pharmaceutical. Glecaprevir was first approved as Mavyret on 2017-07-26. It is used to treat hepatitis c in the USA. It has been approved in Europe to treat chronic hepatitis c. Mavyret’s patents are valid until 2035-06-05 (FDA).
Image (chem structure or protein)